Convergence Investment Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,290
Closed -$618K 274
2024
Q1
$618K Buy
+22,290
New +$495K 0.24% 118
2021
Q3
Sell
-6,797
Closed -$288K 257
2021
Q2
$288K Sell
6,797
-1,946
-22% -$75.7K 0.12% 168
2021
Q1
$329K Buy
8,743
+154
+2% +$4.82K 0.15% 142
2020
Q4
$232K Buy
+8,589
New +$221K 0.12% 161
2018
Q2
Sell
-233
Closed -$4K 713
2018
Q1
$4K Buy
+233
New +$4.15K ﹤0.01% 880
2017
Q4
Sell
-32,045
Closed -$936K 330
2017
Q3
$936K Sell
32,045
-193
-0.6% -$5.7K 0.13% 236
2017
Q2
$1.04M Sell
32,238
-46,947
-59% -$1.54M 0.15% 241
2017
Q1
$2.74M Buy
79,185
+37,449
+90% +$1.34M 0.38% 93
2016
Q4
$1.47M Sell
41,736
-74,882
-64% -$2.53M 0.2% 204
2016
Q3
$4.05M Sell
116,618
-48,468
-29% -$1.7M 0.6% 38
2016
Q2
$6.17M Buy
165,086
+620
+0.4% +$23.3K 0.85% 14
2016
Q1
$6.65M Buy
164,466
+79,253
+93% +$2.95M 0.79% 18
2015
Q4
$3.07M Buy
85,213
+50,552
+146% +$1.83M 0.34% 103
2015
Q3
$1.11M Buy
+34,661
New +$1.18M 0.13% 248
2014
Q3
Sell
-107,687
Closed -$3.66M 409
2014
Q2
$3.66M Buy
107,687
+3,490
+3% +$120K 0.48% 55
2014
Q1
$3.65M Buy
104,197
+23,012
+28% +$812K 0.56% 38
2013
Q4
$2.97M Buy
+81,185
New +$2.98M 0.48% 58

Other funds holding ACH

Convergence Investment Partners's ACH Position: Q2 2024 in Review

Convergence Investment Partners sold out of Accendra Health (ACH) in Q2 2024, closing a stake of 22,290 shares — an estimated $618K sold.

Convergence Investment Partners first reported a position in ACH in Q4 2013 and held it in 17 quarters. The position peaked at $6.65M in Q1 2016. 221 funds tracked by Wall St. Rank hold ACH as of Q2 2024.

  • Convergence Investment Partners reported no remaining Accendra Health position as of Q2 2024 after selling out during the quarter.
  • Convergence Investment Partners sold 22,290 Accendra Health shares in Q2 2024, an estimated $618K.
  • Convergence Investment Partners first reported a position in Accendra Health in Q4 2013 and held it in 17 quarters.
  • Convergence Investment Partners's Accendra Health position peaked at $6.65M in Q1 2016.
  • 221 funds tracked by Wall St. Rank held Accendra Health as of Q2 2024.

Based on Convergence Investment Partners's 13F filing for Q2 2024, filed 1 Aug 2024.